Semaglutide FAQ

Semaglutide is a long-acting analog of a naturally occurring hormone in the body (GLP-1) and was FDA approved in 2021 for the treatment of obesity and well as readily prescribed for the treatment of diabetes since 2017. 

*Individual patient results may vary.

Next Step

If you believe you or someone you care about could be a candidate for Semaglutide treatment, please contact us today.